C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/4353 (2006.01) A61K 31/439 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2636242
Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
L'invention porte sur des composés de formule (I) et leurs sels pharmaceutiquement acceptables inhibant le récepteur des tyrosine kinases et traitant des troubles médiés par elles, et sur des méthodes les utilisant permettant d'effectuer des diagnostics in vitro, in situ et in vivo, et de prévenir ou traiter de tels troubles dans des cellules mammifères ou les états pathologiques associées.
Blake James F.
Boyd Steven
de Meese Jason
Gaudino John J.
Marlow Allison L.
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Heterobicyclic thiophene compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterobicyclic thiophene compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic thiophene compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1717816